Orthopedic Imaging Equipment Market Size, Share & Trends Analysis Report By Modality (X-ray, MRI), By Indication (Trauma Cases, Bone Disorders), By End-use, By Region, And Segment Forecasts, 2025 - 2030

Orthopedic Imaging Equipment Market Growth & Trends

The global orthopedic imaging equipment market size is estimated to reach USD 6.96 billion by 2030, registering to grow at a CAGR of 5.15% from 2025 to 2030 according to a new report by Grand View Research, Inc. The major factors contributing to market growth include increasing cases of orthopedic disorders and injuries, technological advancements, and growing awareness as well as adoption of orthopedic imaging equipment. For instance, according to an article published by Osteoporosis Canada, one out of every three women and one out of every five men will experience an osteoporotic fracture during their lifetime. In addition, it stated that over 80% of fractures in people aged 50 and above are caused by osteoporosis.

These techniques help accurately identify and classify fractures, which, in turn, guides the treatment plan. Each modality has its unique features. X-ray is the most commonly used orthopedic imaging technique. MRI provides excellent visualization of soft tissues, making it ideal for assessing ligaments, tendons, cartilage, and other structures surrounding joints. CT provides superior imaging of bone structures, as it can easily identify bone overlap between images. Ultrasound imaging uses high-frequency sound waves to produce real-time images.

Technological advancements, such as handheld ultrasound, improved resolution, and integration of AI with imaging modalities, are expected to boost market growth. For instance, in February 2023, Clarius Mobile Health announced that its MSK AI model had been granted FDA approval. The model incorporates advanced artificial intelligence (AI) technology to identify and measure tendons in the foot, ankle, and knee with high precision. Clarius Mobile Health is a renowned provider of high-definition handheld ultrasound systems.

Furthermore, companies operating in the market are working to improve their product offerings by upgrading their products, leveraging important cooperative drives, as well as considering acquisitions and government approvals these efforts are aimed at expanding their customer base and gaining a larger share of the market. For instance, in January 2024, Orthofix Medical Inc, a company specializing in spine and orthopedics, entered into a distribution agreement with MRIguidance to offer BoneMRI imaging software in the U.S.

rthopedic Imaging Equipment Market Report Highlights

  • The x-ray segment held the largest market share of over 32.41% in 2024. X-rays are a valuable diagnostic tool primarily utilized for detecting diseases and abnormalities within bone structures.
  • The trauma cases segment held the largest market share of more than 21.09% in 2024, owing to increasing sports injuries and accidents.
  • The hospitals segment dominated the market with a share of over 46.10% in 2024.
  • North America orthopedic imaging equipment market held the largest revenue share of 34.4% in 2024.
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Modality
1.2.2. Indication
1.2.3. End Use
1.2.4. Regional scope
1.2.5. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.4.5. Details of primary research
1.4.5.1. Data for primary interviews in North America
1.4.5.2. Data for primary interviews in Europe
1.4.5.3. Data for primary interviews in Asia Pacific
1.4.5.4. Data for primary interviews in Latin America
1.4.5.5. Data for Primary interviews in MEA
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Approach 1: Commodity flow approach
1.7.3. Volume price analysis (Model 2)
1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Modality outlook
2.2.2. Indication outlook
2.2.3. End use outlook
2.2.4. Regional outlook
2.3. Competitive Insights
Chapter 3. Orthopedic Imaging Equipment Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Growing prevalence of orthopedic disorders and injuries
3.2.1.2. Technological advancements
3.2.2. Market restraint analysis
3.2.2.1. Certain imaging techniques may pose a risk of radiation exposure
3.2.2.2. Orthopedic imaging procedures may face limited reimbursement policies
3.3. Orthopedic Imaging Equipment Market Analysis Tools
3.3.1. Industry Analysis – Porter’s
3.3.1.1. Supplier power
3.3.1.2. Buyer power
3.3.1.3. Substitution threat
3.3.1.4. Threat of new entrant
3.3.1.5. Competitive rivalry
3.3.2. PESTEL Analysis
3.3.2.1. Political landscape
3.3.2.2. Technological landscape
3.3.2.3. Economic landscape
Chapter 4. Orthopedic Imaging Equipment Market: Modality Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Global Orthopedic Imaging Devices Modality Market Movement Analysis
4.3. Global Orthopedic Imaging Equipment Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
4.4. X-ray
4.4.1. X-ray market estimates and forecasts 2018 to 2030 (USD Million)
4.5. CT
4.5.1. CT market estimates and forecasts 2018 to 2030 (USD Million)
4.6. MRI
4.6.1. MRI market estimates and forecasts 2018 to 2030 (USD Million)
4.7. Ultrasound
4.7.1. Ultrasound market estimates and forecasts 2018 to 2030 (USD Million)
4.8. Nuclear Imaging
4.8.1. Nuclear imaging market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Orthopedic Imaging Equipment Market: Indication Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Global Orthopedic Imaging Devices Indication Market Movement Analysis
5.3. Global Orthopedic Imaging Equipment Market Size & Trend Analysis, by Indication, 2018 to 2030 (USD Million)
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
5.5. Trauma Cases
5.5.1. Trauma cases market estimates and forecasts 2018 to 2030 (USD Million)
5.6. Sport Injuries
5.6.1. Sport injuries market estimates and forecasts 2018 to 2030 (USD Million)
5.7. Spinal Injuries
5.7.1. Spinal injuries market estimates and forecasts 2018 to 2030 (USD Million)
5.8. Arthritis
5.8.1. Arthritis market estimates and forecasts 2018 to 2030 (USD Million)
5.9. Bone Disorders
5.9.1. Bone disorders market estimates and forecasts 2018 to 2030 (USD Million)
5.10. Musculoskeletal Cancer
5.10.1. Musculoskeletal cancer market estimates and forecasts 2018 to 2030 (USD Million)
5.11. Muscle Atrophy
5.11.1. Muscle atrophy market estimates and forecasts 2018 to 2030 (USD Million)
5.12. Others
5.12.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Orthopedic Imaging Equipment Market: End Use Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Global Orthopedic Imaging Devices End Use Market Movement Analysis
6.3. Global Orthopedic Imaging Equipment Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
6.4. Hospitals
6.4.1. Hospitals market estimates and forecasts 2018 to 2030 (USD Million)
6.5. Diagnostic Imaging Centers
6.5.1. Diagnostic imaging centers market estimates and forecasts 2018 to 2030 (USD Million)
6.6. Others
6.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Orthopedic Imaging Equipment Market: Regional Estimates & Trend Analysis By Modality, Indication, End Use
7.1. Regional Market Share Analysis, 2024 & 2030
7.2. Regional Market Dashboard
7.3. Global Regional Market Snapshot
7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
7.5. North America
7.5.1. U.S.
7.5.1.1. Key country dynamics
7.5.1.2. Competitive scenario
7.5.1.3. Regulatory framework/ reimbursement structure
7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
7.5.2. Canada
7.5.2.1. Key country dynamics
7.5.2.2. Competitive scenario
7.5.2.3. Regulatory framework/ reimbursement structure
7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
7.5.3. Mexico
7.5.3.1. Key country dynamics
7.5.3.2. Competitive scenario
7.5.3.3. Regulatory framework/ reimbursement structure
7.5.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Europe
7.6.1. Regulatory framework/ reimbursement structure
7.6.2. UK
7.6.2.1. Key country dynamics
7.6.2.2. Competitive scenario
7.6.2.3. Regulatory framework/ reimbursement structure
7.6.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
7.6.3. Germany
7.6.3.1. Key country dynamics
7.6.3.2. Competitive scenario
7.6.3.3. Regulatory framework/ reimbursement structure
7.6.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
7.6.4. France
7.6.4.1. Key country dynamics
7.6.4.2. Competitive scenario
7.6.4.3. Regulatory framework/ reimbursement structure
7.6.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
7.6.5. Italy
7.6.5.1. Key country dynamics
7.6.5.2. Competitive scenario
7.6.5.3. Regulatory framework/ reimbursement structure
7.6.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
7.6.6. Spain
7.6.6.1. Key country dynamics
7.6.6.2. Competitive scenario
7.6.6.3. Regulatory framework/ reimbursement structure
7.6.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
7.6.7. Norway
7.6.7.1. Key country dynamics
7.6.7.2. Competitive scenario
7.6.7.3. Regulatory framework/ reimbursement structure
7.6.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
7.6.8. Sweden
7.6.8.1. Key country dynamics
7.6.8.2. Competitive scenario
7.6.8.3. Regulatory framework/ reimbursement structure
7.6.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
7.6.9. Denmark
7.6.9.1. Key country dynamics
7.6.9.2. Competitive scenario
7.6.9.3. Regulatory framework/ reimbursement structure
7.6.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.7. Asia Pacific
7.7.1. Regulatory framework/ reimbursement structure
7.7.2. Japan
7.7.2.1. Key country dynamics
7.7.2.2. Competitive scenario
7.7.2.3. Regulatory framework/ reimbursement structure
7.7.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
7.7.3. China
7.7.3.1. Key country dynamics
7.7.3.2. Competitive scenario
7.7.3.3. Regulatory framework/ reimbursement structure
7.7.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
7.7.4. India
7.7.4.1. Key country dynamics
7.7.4.2. Competitive scenario
7.7.4.3. Regulatory framework/ reimbursement structure
7.7.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
7.7.5. Australia
7.7.5.1. Key country dynamics
7.7.5.2. Competitive scenario
7.7.5.3. Regulatory framework/ reimbursement structure
7.7.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
7.7.6. South Korea
7.7.6.1. Key country dynamics
7.7.6.2. Competitive scenario
7.7.6.3. Regulatory framework/ reimbursement structure
7.7.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
7.7.7. Thailand
7.7.7.1. Key country dynamics
7.7.7.2. Competitive scenario
7.7.7.3. Regulatory framework/ reimbursement structure
7.7.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.8. Latin America
7.8.1. Regulatory framework/ reimbursement structure
7.8.2. Brazil
7.8.2.1. Key country dynamics
7.8.2.2. Competitive scenario
7.8.2.3. Regulatory framework/ reimbursement structure
7.8.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
7.8.3. Argentina
7.8.3.1. Key country dynamics
7.8.3.2. Competitive scenario
7.8.3.3. Regulatory framework/ reimbursement structure
7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.9. MEA
7.9.1. Regulatory framework/ reimbursement structure
7.9.2. South Africa
7.9.2.1. Key country dynamics
7.9.2.2. Competitive scenario
7.9.2.3. Regulatory framework/ reimbursement structure
7.9.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
7.9.3. Saudi Arabia
7.9.3.1. Key country dynamics
7.9.3.2. Competitive scenario
7.9.3.3. Regulatory framework/ reimbursement structure
7.9.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
7.9.4. UAE
7.9.4.1. Key country dynamics
7.9.4.2. Competitive scenario
7.9.4.3. Regulatory framework/ reimbursement structure
7.9.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
7.9.5. Kuwait
7.9.5.1. Key country dynamics
7.9.5.2. Competitive scenario
7.9.5.3. Regulatory framework/ reimbursement structure
7.9.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company/Competition Categorization
8.3. Key company market share analysis, 2024
8.4. Company Position Analysis
8.5. Company Categorization (Emerging Players, Innovators and Leaders
8.6. Company Profiles
8.6.1. GE Healthcare
8.6.1.1. Company overview
8.6.1.2. Financial performance
8.6.1.3. Product benchmarking
8.6.1.4. Strategic initiatives
8.6.2. Philips Healthcare
8.6.2.1. Company overview
8.6.2.2. Financial performance
8.6.2.3. Product benchmarking
8.6.2.4. Strategic initiatives
8.6.3. Siemens Healthineers
8.6.3.1. Company overview
8.6.3.2. Financial performance
8.6.3.3. Product benchmarking
8.6.3.4. Strategic initiatives
8.6.4. Canon Medical Systems Corporation
8.6.4.1. Company overview
8.6.4.2. Financial performance
8.6.4.3. Product benchmarking
8.6.4.4. Strategic initiatives
8.6.5. Fujifilm Healthcare Solutions
8.6.5.1. Company overview
8.6.5.2. Financial performance
8.6.5.3. Product benchmarking
8.6.5.4. Strategic initiatives
8.6.6. Esaote
8.6.6.1. Company overview
8.6.6.2. Financial performance
8.6.6.3. Product benchmarking
8.6.6.4. Strategic initiatives
8.6.7. Carestream Health
8.6.7.1. Company overview
8.6.7.2. Financial performance
8.6.7.3. Product benchmarking
8.6.7.4. Strategic initiatives
8.6.8. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
8.6.8.1. Company overview
8.6.8.2. Financial performance
8.6.8.3. Product benchmarking
8.6.8.4. Strategic initiatives
8.6.9. United Imaging Healthcare Co.
8.6.9.1. Company overview
8.6.9.2. Financial performance
8.6.9.3. Product benchmarking
8.6.9.4. Strategic initiatives
8.6.10. Shimadzu Corporation
8.6.10.1. Company overview
8.6.10.2. Financial performance
8.6.10.3. Product benchmarking
8.6.10.4. Strategic initiatives
8.6.11. Hologic, Inc.
8.6.11.1. Company overview
8.6.11.2. Financial performance
8.6.11.3. Product benchmarking
8.6.11.4. Strategic initiatives
Chapter 9. Analyst Perspective

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings